Publications
5532 Results
- Journal / Conference
- AJCO 16(4):359-362
- Year
- 1993
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8804
Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma: A Southwest Oncology Group study.
- Journal / Conference
- IND 11:337-341
- Year
- 1993
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-8930
Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.
- Journal / Conference
- IND 11:227-229
- Year
- 1993
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-8932
Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group trial.
- Journal / Conference
- IND 11:329-331
- Year
- 1993
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8933
A phase II trial of piroxantrone in adenocarcinoma of the pancreas: A Southwest Oncology Group study.
- Journal / Conference
- ASCO 12:176(#501)
- Year
- 1993
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9016
A phase II study of external beam radiation and chemotherapy with cisplatin/BCNU followed by BCNU alone of the treatment of incompletely resected high grade brain tumors: Preliminary results of a Southwest Oncology Group (SWOG) study (SWOG-9016).
- Journal / Conference
- American Urological Association Inc. 149:308A(#360)
- Year
- 1993
In the era of prostate specific antigen (PSA), is prostate acid phosphatase (PAP) necessary for staging prostate cancer? A Southwest Oncology Group study.
- Journal / Conference
- Malignant Lymphomas Including Hodgkins Disease 4:53-63
- Year
- 1993
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14
Treatment of diffuse large-cell lymphoma: A summary of outcome for patients treated by the Southwest Oncology Group.
- Journal / Conference
- Oncology 50(Suppl.2):2-9
- Year
- 1993
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8412
Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer.
- Journal / Conference
- Leukemia & Lymphoma 12:1-10
- Year
- 1993
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
NCAM (CD56)-positive malignant lymphoma.
- Journal / Conference
- Blood 81(11):2860-2865
- Year
- 1993
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8600, SWOG-8750, SWOG-9007, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120)